GABRP and cancer: Its cancer‐promoting phenotype needs to be verified through in vitro experiments (such as inhibition of tumor cell proliferation/migration after knocking down GABRP) and in vivo models (delayed growth of mouse transplanted tumors) to clarify the biological basis of clinical association.